Immunodominant fragments of myelin basic protein initiate T cell-dependent pain

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Liu, Huaqing ^a,b   Shiryaev, Sergey A ^c   Chernov, Andrei V ^c   Kim, Youngsoon ^a,b   Shubayev, Igor ^b   Remacle, Albert G ^c   Baranovskaya, Svetlana ^d   Golubkov, Vladislav S ^c   Strongin, Alex Y ^c   Shubayev, Veronica I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c BURNHAM INSTITUTE   (United States)

^d AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 17; LIVER X RECEPTOR; MYELIN BASIC PROTEIN; RETINOID X RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ALLODYNIA; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; IMMUNOGENICITY; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE INJURY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RAT; SCHWANN CELL; SCIATIC NERVE INJURY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84861905736     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-119     Document Type: Article

References (82)

1. Devor M. Ectopic discharge in Abeta afferents as a source of neuropathic pain. Exp Brain Res 2009, 196:115-128. 10.1007/s00221-009-1724-6, 19242687.
2. Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain 2006, Suppl 1:S3-S12.
3. Wu G, Ringkamp M, Murinson BB, Pogatzki EM, Hartke TV, Weerahandi HM, Campbell JN, Griffin JW, Meyer RA. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci 2002, 22:7746-7753.
4. Henry MA, Luo S, Foley BD, Rzasa RS, Johnson LR, Levinson SR. Sodium channel expression and localization at demyelinated sites in painful human dental pulp. J Pain 2009, 10:750-758. 10.1016/j.jpain.2009.01.264, 2750027, 19559391.
5. Kobayashi H, Chattopadhyay S, Kato K, Dolkas J, Kikuchi S, Myers RR, Shubayev VI. MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage. Mol Cell Neurosci 2008, 39:619-627. 10.1016/j.mcn.2008.08.008, 2865888, 18817874.
6. Zhu YL, Xie ZL, Wu YW, Duan WR, Xie YK. Early demyelination of primary A-fibers induces a rapid-onset of neuropathic pain in rat. Neuroscience 2012, 200:186-198.
7. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635. 10.1212/01.wnl.0000282763.29778.59, 18003941.
8. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10:1361-1368. 10.1038/nn1992, 17965656.
9. Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 2004, 129:767-777. 10.1016/j.neuroscience.2004.08.035, 15541898.
10. Tsai YC, Won SJ. Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury. Pain 2001, 92:63-69. 10.1016/S0304-3959(00)00472-3, 11323127.
11. Kleinschnitz C, Hofstetter HH, Meuth SG, Braeuninger S, Sommer C, Stoll G. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol 2006, 200:480-485. 10.1016/j.expneurol.2006.03.014, 16674943.
12. Cao L, DeLeo JA. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol 2008, 38:448-458. 10.1002/eji.200737485, 2963094, 18196515.
13. Sweitzer SM, Hickey WF, Rutkowski MD, Pahl JL, DeLeo JA. Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain 2002, 100:163-170. 10.1016/S0304-3959(02)00257-9, 12435469.
14. Costigan M, Moss A, Latremoliere A, Johnston C, Verma-Gandhu M, Herbert TA, Barrett L, Brenner GJ, Vardeh D, Woolf CJ, Fitzgerald M. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci 2009, 29:14415-14422. 10.1523/JNEUROSCI.4569-09.2009, 2813708, 19923276.
15. Kim CF, Moalem-Taylor G. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain 2011, 12:370-383.
16. Sweitzer SM, White KA, Dutta C, DeLeo JA. The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents. J Neuroimmunol 2002, 125:82-93. 10.1016/S0165-5728(02)00036-X, 11960644.
17. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010, 229:26-50. 10.1016/j.jneuroim.2010.08.013, 20870295.
18. Hu P, Bembrick AL, Keay KA, McLachlan EM. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. Brain Behav Immun 2007, 21:599-616. 10.1016/j.bbi.2006.10.013, 17187959.
19. Alzate O, Hussain SR, Goettl VM, Tewari AK, Madiai F, Stephens RL, Hackshaw KV. Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. Brain Res Mol Brain Res 2004, 128:193-200.
20. Salzer JL. Polarized domains of myelinated axons. Neuron 2003, 40:297-318. 10.1016/S0896-6273(03)00628-7, 14556710.
21. Givogri MI, Bongarzone ER, Campagnoni AT. New insights on the biology of myelin basic protein gene: the neural-immune connection. J Neurosci Res 2000, 59:153-159. 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.0.CO;2-F, 10650873.
22. Garbay B, Heape AM, Sarqueil F, Cassagne C. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 2000, 61:267-304. 10.1016/S0301-0082(99)00049-0, 10727776.
23. Boggs JM. Myelin basic protein: a multifunctional protein. Cell Mol Life Sci 2006, 63:1945-1961. 10.1007/s00018-006-6094-7, 16794783.
24. Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Brain Behav Immun 2007, 21:699-710. 10.1016/j.bbi.2006.07.007, 17005365.
25. Vargas ME, Watanabe J, Singh SJ, Robinson WH, Barres BA. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc Natl Acad Sci U S A 2010, 107:11993-11998. 10.1073/pnas.1001948107, 2900702, 20547838.
26. Marty MC, Alliot F, Rutin J, Fritz R, Trisler D, Pessac B. The myelin basic protein gene is expressed in differentiated blood cell lineages and in hemopoietic progenitors. Proc Natl Acad Sci U S A 2002, 99:8856-8861. 10.1073/pnas.122079599, 124388, 12084930.
27. Shiryaev SA, Savinov AY, Cieplak P, Ratnikov BI, Motamedchaboki K, Smith JW, Strongin AY. Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis. PLoS One 2009, 4:e4952. 10.1371/journal.pone.0004952, 2654159, 19300513.
28. Proost P, Van Damme J, Opdenakker G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem Biophys Res Commun 1993, 192:1175-1181. 10.1006/bbrc.1993.1540, 7685161.
29. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573. 10.1016/j.cardiores.2005.12.002, 16405877.
30. Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR. TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 2006, 31:407-415. 10.1016/j.mcn.2005.10.011, 16297636.
31. Kieseier BC, Hartung HP, Wiendl H. Immune circuitry in the peripheral nervous system. Curr Opin Neurol 2006, 19:437-445. 10.1097/01.wco.0000245365.51823.72, 16969152.
32. Chattopadhyay S, Myers RR, Janes J, Shubayev V. Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav Immun 2007, 21:561-568. 10.1016/j.bbi.2006.10.015, 2865892, 17189680.
33. Kawasaki Y, Xu Z-Z, Wang X, Park JY, Zhuang Z-Y, Tan P-H, Gao Y-J, Roy K, Corfas G, Lo EH, Ji R-R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336. 10.1038/nm1723, 2279180, 18264108.
34. Dev R, Srivastava PK, Iyer JP, Dastidar SG, Ray A. Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain. Expert Opin Investig Drugs 2010, 19:455-468. 10.1517/13543781003643486, 20218929.
35. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107. 10.1016/0304-3959(88)90209-6, 2837713.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
37. Shiryaev SA, Remacle AG, Savinov AY, Chernov AV, Cieplak P, Radichev IA, Williams R, Shiryaeva TN, Gawlik K, Postnova TI, Ratnikov BI, Eroshkin AM, Motamedchaboki K, Smith JW, Strongin AY. Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. J Biol Chem 2009, 284:30615-30626. 10.1074/jbc.M109.041244, 2781616, 19726693.
38. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9, 7990513.
39. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88. 10.1016/0304-3959(88)90026-7, 3340425.
40. Attal N, Jazat F, Kayser V, Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain 1990, 41:235-251. 10.1016/0304-3959(90)90022-6, 2164179.
41. Backonja M, Woolf CJ. Future directions in neuropathic pain therapy: closing the translational loop. Oncologist 2010, Suppl 2:24-29.
42. Costigan M. Pain's peptide signature. Pain 2012, 153:509-510. 10.1016/j.pain.2012.01.004, 22264678.
43. Kim CF, Moalem-Taylor G. Detailed characterization of neuro-immune responses following neuropathic injury in mice. Brain Res 2011, 1405:95-108.
44. Kim Y, Remacle AG, Chernov AV, Liu H, Shubayev I, Lai C, Dolkas J, Shiryaev SA, Golubkov VS, Mizisin AP, Strongin AY, Shubayev VI. The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration. PLoS One 2012, 7:e33664. 10.1371/journal.pone.0033664, 3306282, 22438979.
45. Shubayev VI, Myers RR. Endoneurial remodeling by TNFalpha- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J Peripher Nerv Syst 2002, 7:28-36. 10.1046/j.1529-8027.2002.02003.x, 11939349.
46. Shubayev VI, Myers RR. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000, 855:83-89. 10.1016/S0006-8993(99)02321-5, 10650133.
47. Brown S, Bernardo MM, Li Z-H, Kotra LP, Tanaka Y, Fridman R, Mobashery S. Potent and selective mechanism-based inhibition of gelatinases. J Am Chem Soc 2000, 122:6799-6800.
48. Liu H, Shubayev VI. Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury. Exp Neurol 2011, 231:236-246. 10.1016/j.expneurol.2011.06.015, 21756907.
49. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005, 25:6401-6408. 10.1523/JNEUROSCI.1563-05.2005, 16000631.
50. Gould KE, Swanborg RH. T and B cell responses to myelin basic protein and encephalitogenic epitopes. J Neuroimmunol 1993, 46:193-198. 10.1016/0165-5728(93)90249-X, 7689588.
51. Katsara M, Deraos G, Tselios T, Matsoukas J, Apostolopoulos V. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice. J Med Chem 2008, 51:3971-3978. 10.1021/jm8000554, 18563891.
52. Matsoukas J, Apostolopoulos V, Kalbacher H, Papini AM, Tselios T, Chatzantoni K, Biagioli T, Lolli F, Deraos S, Papathanassopoulos P, Troganis A, Mantzourani E, Mavromoutsakos T, Mouzaki A. Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators. J Med Chem 2005, 48:1470-1480. 10.1021/jm040849g, 15743189.
53. Stepaniak JA, Gould KE, Swanborg RH. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog. J Neurosci Res 1996, 45:447-454. 10.1002/(SICI)1097-4547(19960815)45:4<447::AID-JNR14>3.0.CO;2-Y, 8872905.
54. Tselios T, Apostolopoulos V, Daliani I, Deraos S, Grdadolnik S, Mavromoustakos T, Melachrinou M, Thymianou S, Probert L, Mouzaki A, Matsoukas J. Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation. J Med Chem 2002, 45:275-283. 10.1021/jm0102147, 11784132.
55. Matsuo A, Lee GC, Terai K, Takami K, Hickey WF, McGeer EG, McGeer PL. Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am J Pathol 1997, 150:1253-1266. 1858181, 9094982.
56. Chattopadhyay S, Shubayev VI. MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway. GLIA 2009, 57:1316-1325. 10.1002/glia.20851, 2713381, 19229995.
57. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007, 105:838-847. 10.1213/01.ane.0000275190.42912.37, 17717248.
58. Myers RR, Campana WM, Shubayev VI. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 2006, 11:8-20. 10.1016/S1359-6446(05)03637-8, 16478686.
59. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int 2004, 45:389-395. 10.1016/j.neuint.2003.09.009, 15145553.
60. Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med 2010, 16:1267-1276. 10.1038/nm.2234, 3077564, 20948535.
61. Djouhri L, Lawson SN. Abeta-fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent A-fiber neurons in mammals. Brain Res Brain Res Rev 2004, 46:131-145.
62. D'Souza CA, Moscarello MA. Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope. Neurochem Res 2006, 31:1045-1054. 10.1007/s11064-006-9116-9, 16871440.
63. Chandler S, Coates R, Gearing A, Lury J, Well G, Bone E. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 1995, 201:223-226. 10.1016/0304-3940(95)12173-0, 8786845.
64. Campagnoni AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, Landry CF, Handley VW, Newman SL, Garbay B, Kitamura K. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem 1993, 268:4930-4938.
65. Filipovic R, Rakic S, Zecevic N. Expression of Golli proteins in adult human brain and multiple sclerosis lesions. J Neuroimmunol 2002, 127:1-12. 10.1016/S0165-5728(02)00070-X, 12044969.
66. Tienari PJ, Kuokkanen S, Pastinen T, Wikstrom J, Sajantila A, Sandberg-Wolheim M, Palo J, Peltonen L. Golli-MBP gene in multiple sclerosis susceptibility. J Neuroimmunol 1998, 81:158-167. 10.1016/S0165-5728(97)00171-9, 9521617.
67. Myers RR, Shubayev VI. The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF-alpha axonal transport in neuropathic pain. J Peripher Nerv Syst 2011, 16:277-286. 10.1111/j.1529-8027.2011.00362.x, 22176142.
68. Meyerzu Horste G, Hu W, Hartung HP, Lehmann HC, Kieseier BC. The immunocompetence of Schwann cells. Muscle Nerve 2008, 37:3-13. 10.1002/mus.20893, 17823955.
69. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow?. Annu Rev Neurosci 2007, 30:153-179. 10.1146/annurev.neuro.30.051606.094354, 17506644.
70. Feng JM, Fernandes AO, Campagnoni CW, Hu YH, Campagnoni AT. The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes. J Neuroimmunol 2004, 152:57-66. 10.1016/j.jneuroim.2004.03.021, 15223237.
71. Paez PM, Spreuer V, Handley V, Feng JM, Campagnoni C, Campagnoni AT. Increased expression of golli myelin basic proteins enhances calcium influx into oligodendroglial cells. J Neurosci 2007, 27:12690-12699. 10.1523/JNEUROSCI.2381-07.2007, 18003849.
72. Smith GS, Paez PM, Spreuer V, Campagnoni CW, Boggs JM, Campagnoni AT, Harauz G. Classical 18.5-and 21.5-kDa isoforms of myelin basic protein inhibit calcium influx into oligodendroglial cells, in contrast to golli isoforms. J Neurosci Res 2011, 89:467-480. 10.1002/jnr.22570, 21312222.
73. Yaksh TL. Calcium channels as therapeutic targets in neuropathic pain. J Pain 2006, Suppl 1:S13-30.
74. Fernandez-Valle C, Bunge RP, Bunge MB. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J Neurocytol 1995, 24:667-679. 10.1007/BF01179817, 7500122.
75. Bruck W. The role of macrophages in Wallerian degeneration. Brain Pathol 1997, 7:741-752. 10.1111/j.1750-3639.1997.tb01060.x, 9161725.
76. Stoll G, Griffin JW, Li CY, Trapp BD. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989, 18:671-683. 10.1007/BF01187086, 2614485.
77. Wekerle H, Schwab M, Linington C, Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 1986, 16:1551-1557. 10.1002/eji.1830161214, 2434335.
78. Lilje O. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol Life Sci 2002, 59:2191-2198. 10.1007/s000180200018, 12568345.
79. Shir Y, Seltzer Z. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett 1990, 115:62-67. 10.1016/0304-3940(90)90518-E, 2216058.
80. Ossipov MH, Bian D, Malan TP, Lai J, Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 1999, 79:127-133. 10.1016/S0304-3959(98)00187-0, 10068158.
81. Cheng C, Zochodne DW. In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience 2002, 115:321-329. 10.1016/S0306-4522(02)00291-9, 12401344.
82. Solaro C, Messmer Uccelli M. Pharmacological management of pain in patients with multiple sclerosis. Drugs 2010, 70:1245-1254.